The Toponome of Virus Infected Skin

病毒感染皮肤的地形图

基本信息

项目摘要

Abstract Viral skin infections are a significant cause of morbidity and mortality in the human populations, with millions of individuals infected worldwide with the poxvirus molluscum contagiosum virus (MCV), which is only held in check by the host immune system as immunocompromised individuals present with debilitating systemic infection. The related poxvirus Vaccinia virus (VACV) was used to immunize hundreds of millions of people during the smallpox eradication program, and remains a backbone of the most widely used viral vaccine vectors. During virus infection there is a significant change in the morphology of a target organ caused by cellular fusion during progression of the virus life cycle, as well as by the influx of a large variety of responding immune cells. The inflammation produced by infection can also stimulate the differentiation of non-classical populations of resident or infiltrating cells that do not resemble cells typically present in the steady state. Therefore, the complex phenotyping of these cells requires the use of large panels of probes (mostly antibodies). However, traditional methods (microscopy, flow cytometry, proteomics or genomics) do not allow simultaneous analysis of protein expression by individual cells, quantification and topological localization of cells and proteins relative to each other without damaging and confounding tissue dissociation, or analysis of 50-100 parameters from a single tissue. In order to accomplish this investigation we will perform non-invasive analysis of 50+ parameters using a Toponome Imaging System, an imaging cycler microscope that is a fully automated microscope that allows the spatial resolution of large molecular and cellular systems displaying many thousands of potential interactions in intact tissues. We will analyze the molecular and cellular changes in the skin at different points after infection of the skin of mice with using VACV (a model for poxvirus infection). We hypothesize that multiplexed toponomic analysis will reveal a unique molecular and cellular signature poxviral skin infection. In Aim 1 we will optimize staining protocols and examine and validate infection, localization and phenotype of resident and infiltrating cell populations during the initiation, control and resolution phases of VACV dermal infection. In Aim 2 we will examine the role of two individual meyloid cell populations in establishing both the morphology of the VACV lesion and the function of infiltrating cells. We anticipate that the results gained from these studies will form the basis of a future RO1 or PO1 proposal in which the mechanisms by which infected, resident and infiltrating cell populations interact in viral skin infections, with potential for the use of clinical samples to validate out studies in humans.
抽象的 病毒性皮肤感染是导致人类发病和死亡的一个重要原因,有数百万人 全世界感染痘病毒传染性软疣病毒 (MCV) 的个体,这种病毒仅存在于 由宿主免疫系统检查,因为免疫功能低下的个体出现全身衰弱的情况 感染。相关的痘病毒痘苗病毒(VACV)被用来为数亿人提供免疫 在天花根除计划期间,仍然是最广泛使用的病毒疫苗的支柱 向量。病毒感染期间,靶器官的形态发生显着变化,原因是 病毒生命周期进展过程中的细胞融合,以及多种反应物的涌入 免疫细胞。感染产生的炎症也可以刺激非经典细胞的分化。 驻留或浸润细胞群与通常存在于稳态的细胞不同。 因此,这些细胞的复杂表型分析需要使用大量的探针(大部分是 抗体)。然而,传统方法(显微镜、流式细胞术、蛋白质组学或基因组学)不允许 同时分析单个细胞的蛋白质表达、定量和拓扑定位 细胞和蛋白质之间的相对关系,不会破坏和混淆组织解离,或分析 来自单个组织的 50-100 个参数。为了完成这项调查,我们将进行非侵入性的 使用 Toponome 成像系统(一种完全集成的成像循环仪显微镜)分析 50 多个参数 自动显微镜,允许大分子和细胞系统的空间分辨率显示 完整组织中存在数千种潜在的相互作用。我们将分析分子和细胞的变化 使用 VACV(痘病毒感染模型)感染小鼠皮肤后不同点的皮肤。 我们假设多重拓扑分析将揭示独特的分子和细胞特征 痘病毒皮肤感染。在目标 1 中,我们将优化染色方案并检查和验证感染, 在启动、控制和过程中驻留和浸润细胞群的定位和表型 VACV 皮肤感染的消退阶段。在目标 2 中,我们将检查两个单独的髓样细胞的作用 群体建立 VACV 病变的形态和浸润细胞的功能。我们 预计从这些研究中获得的结果将构成未来 RO1 或 PO1 提案的基础 感染细胞群、常驻细胞群和浸润细胞群在病毒皮肤中相互作用的机制 感染,有可能使用临床样本来验证人体研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher C Norbury其他文献

Christopher C Norbury的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher C Norbury', 18)}}的其他基金

How does Cytomegalovirus use interferon lambda for optimal spread
巨细胞病毒如何利用 lambda 干扰素实现最佳传播
  • 批准号:
    10552002
  • 财政年份:
    2022
  • 资助金额:
    $ 19.34万
  • 项目类别:
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNs
局部病毒感染对皮肤伤口愈合的影响:病毒诱导的III型干扰素的影响
  • 批准号:
    10433972
  • 财政年份:
    2021
  • 资助金额:
    $ 19.34万
  • 项目类别:
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNs
局部病毒感染对皮肤伤口愈合的影响:病毒诱导的III型干扰素的影响
  • 批准号:
    10217681
  • 财政年份:
    2021
  • 资助金额:
    $ 19.34万
  • 项目类别:
Interferon-independent STAT1-mediated protective antiviral immunity
不依赖干扰素的STAT1介导的保护性抗病毒免疫
  • 批准号:
    9378819
  • 财政年份:
    2017
  • 资助金额:
    $ 19.34万
  • 项目类别:
Analysis of the mechanism of HCMV cytoplasmic envelopment
HCMV胞质包膜机制分析
  • 批准号:
    10659275
  • 财政年份:
    2017
  • 资助金额:
    $ 19.34万
  • 项目类别:
Poxviruses and Pro-Resolving Lipids
痘病毒和促溶解脂质
  • 批准号:
    8808629
  • 财政年份:
    2014
  • 资助金额:
    $ 19.34万
  • 项目类别:
Viral Manipulation of Myeloid Cell Function
病毒操纵骨髓细胞功能
  • 批准号:
    8450749
  • 财政年份:
    2012
  • 资助金额:
    $ 19.34万
  • 项目类别:
Viral Manipulation of Myeloid Cell Function
病毒操纵骨髓细胞功能
  • 批准号:
    8226379
  • 财政年份:
    2012
  • 资助金额:
    $ 19.34万
  • 项目类别:
Histology and Imaging Core
组织学和成像核心
  • 批准号:
    7746214
  • 财政年份:
    2009
  • 资助金额:
    $ 19.34万
  • 项目类别:
Processing & Presentation of Ectromelia Virus to CD4+ T Lymphocytes - Asso Projec
加工
  • 批准号:
    7982871
  • 财政年份:
    2009
  • 资助金额:
    $ 19.34万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.34万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了